[Progressive spinal amyotrophy type I or Werdnig-Hoffman disease. Apropos of 5 cases in Dakar (Senegal)]

O Ndiaye1, G Sall, A Sylla

  • 1Service de pédiatrie, Hôpital Abass Ndao de Dakar, Université Cheikh Anta Diop de Dakar, Sénégal. oussoundiaye@aol.fr

Insights

Type I spinal muscular atrophy (SMA), also known as Werdnig-Hoffman disease, is rarely documented in Black populations. This study highlights five pediatric cases diagnosed in Dakar, emphasizing SMA as a consideration for severe infantile hypotonia.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Context:

  • Type I spinal muscular atrophy (SMA), or Werdnig-Hoffman disease, is infrequently reported in individuals of Black African descent.
  • This study focuses on pediatric cases diagnosed in Dakar, Senegal.

Purpose:

  • To report on the occurrence and characteristics of Type I SMA in a Black African population.
  • To raise awareness of SMA as a potential diagnosis in infants presenting with severe hypotonia.

Summary:

  • Five cases of Type I SMA were diagnosed in a pediatric outpatient clinic in Dakar.
  • Patients presented with progressive hypotonia since birth, confirmed by electromyography showing peripheral nerve involvement without nerve conduction abnormalities.
  • The mean age of diagnosis was 12.3 months, with respiratory distress noted in two patients. Family history revealed similar symptoms in one case and consanguinity in two.

Impact:

  • This research underscores the importance of considering spinal muscular atrophy in the differential diagnosis of severe hypotonia in infants, irrespective of ethnicity.
  • It contributes to the limited literature on SMA prevalence and presentation in Sub-Saharan African populations.
  • Further research is needed to understand the genetic and environmental factors influencing SMA in diverse populations.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...